Lebesque J V, Bruce A M, Kroes A P, Touw A, Shouman R T, van Herk M
Radiotherapy Department, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam, The Netherlands.
Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1109-19. doi: 10.1016/0360-3016(95)00253-7.
To determine the pattern of changes of rectum and bladder structures during conformal therapy of T3 prostate cancer and the impact of these changes on the accuracy of the dose-volume histograms (DVHs) and normal tissue complication probabilities (NTCPs) of these organs, based on the planning computed tomography (CT) scan only.
For 11 T3 prostate cancer patients treated with conformal therapy, three repeat CT scans were made in Weeks 2, 4, and 6 of the treatment. The bony anatomy was aligned with the planning CT scan, using three dimensional (3D) chamfer matching. The internal and external surfaces of rectum and bladder were contoured in each scan. Three volumes were calculated for each organ: solid organ (including filling), filling, and wall volume. DVHs and NTCPs were calculated for all structures.
The solid organ and filling volumes varied considerably between patients and within a patient and they decreased with increasing treatment time. The largest patient variation was seen for patients with large initial filling volumes. The variations of rectum and bladder wall volumes during treatment were 9 and 17% (1 standard deviation (SD)), respectively, with no time trend. The changes of the high dose (> 80 and 90% of the prescribed dose) volumes of the rectum in response to rectum filling differences were proportional to the whole rectum volume changes. The variation of the high-dose rectum wall volume was relatively small (14%, 1 SD). As a result, the NTCPs of rectum and rectum wall were the same overall and the variation of the NTCPs during treatment was about 14% (1 SD) and not correlated with rectum filling. The variation of the high-dose bladder volumes (about 14%, 1 SD) was smaller than the variation of the whole bladder volumes (30%, 1 SD). The high-dose bladder wall volume decreased significantly due to wall distention as the bladder filling increased. As a result of this complex pattern, the variation of NTCPs of bladder (85%, 1 SD) and bladder wall (88%, 1 SD) during treatment was large and significantly correlated with bladder filling.
The planning CT scan overestimates rectum and bladder filling during treatment. Furthermore, the variation of filling is so large that only the wall structures have relatively constant volumes during treatment. For the rectum wall, the DVHs and NTCPs, as estimated from the initial scan, are representative for the whole treatment, because no correlation was seen between these parameters and organ filling. For the bladder wall, however, such a correlation was present and consequently, the initial bladder wall DVHs and NTCPs can only be representative for the whole treatment, if the bladder filling can be kept reasonably constant during treatment.
仅基于计划计算机断层扫描(CT),确定T3期前列腺癌适形治疗期间直肠和膀胱结构的变化模式,以及这些变化对这些器官的剂量体积直方图(DVH)和正常组织并发症概率(NTCP)准确性的影响。
对于11例接受适形治疗的T3期前列腺癌患者,在治疗的第2周、第4周和第6周进行了三次重复CT扫描。使用三维(3D)倒角匹配将骨骼解剖结构与计划CT扫描对齐。在每次扫描中勾勒出直肠和膀胱的内、外表面。为每个器官计算三个体积:实体器官(包括充盈)、充盈和壁体积。计算所有结构的DVH和NTCP。
实体器官和充盈体积在患者之间以及同一患者内差异很大,并且随着治疗时间的增加而减小。初始充盈体积大的患者差异最大。治疗期间直肠和膀胱壁体积的变化分别为9%和17%(1个标准差(SD)),无时间趋势。直肠高剂量(>规定剂量的80%和90%)体积随直肠充盈差异的变化与整个直肠体积变化成正比。高剂量直肠壁体积的变化相对较小(14%,1个SD)。因此,直肠和直肠壁的NTCP总体相同,治疗期间NTCP的变化约为14%(1个SD),且与直肠充盈无关。高剂量膀胱体积的变化(约14%,1个SD)小于整个膀胱体积的变化(30%,1个SD)。随着膀胱充盈增加,由于壁扩张,高剂量膀胱壁体积显著减小。由于这种复杂模式,治疗期间膀胱(85%,1个SD)和膀胱壁(88%,1个SD)的NTCP变化很大,且与膀胱充盈显著相关。
计划CT扫描高估了治疗期间的直肠和膀胱充盈。此外,充盈变化如此之大,以至于在治疗期间只有壁结构的体积相对恒定。对于直肠壁,根据初始扫描估计的DVH和NTCP代表整个治疗过程,因为这些参数与器官充盈之间没有相关性。然而,对于膀胱壁,存在这种相关性,因此,如果治疗期间膀胱充盈能够保持合理恒定,初始膀胱壁DVH和NTCP才能代表整个治疗过程。